Damora Therapeutics (DMRA) Other Non-Current Assets (2019 - 2026)

Damora Therapeutics (DMRA) has 8 years of Other Non-Current Assets data on file, last reported at $34000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 89.27% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $34000.0 (down 89.27% YoY), and the FY2025 full-year result was $104000.0, down 36.2% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $34000.0, down from $104000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.0 million in Q2 2022 and bottomed at $34000.0 in Q1 2026.
• The 5-year median for Other Non-Current Assets is $2.0 million (2024), against an average of $1.6 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets jumped 1320.3%; it then tumbled 89.27% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $2.3 million in 2022, then sank by 50.5% to $1.1 million in 2023, then sank by 85.55% to $163000.0 in 2024, then slumped by 36.2% to $104000.0 in 2025, then tumbled by 67.31% to $34000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $34000.0 (Q1 2026), $104000.0 (Q4 2025), and $837000.0 (Q3 2025), per Business Quant data.

Peer Comparison